• Analysts tip Biogen to file for aducanumab approval within weeks

    12 days ago - By Fierce Biotech

    Analysts at Jefferies expect Biogen to file for approval of aducanumab in Alzheimer's disease within weeks. Biogen, for its part, is keeping mum about its plans, stating only that it is preparing modules of the common technical document for submission to the FDA.
    Read more ...